Structure–function relationships of the variable domains of monoclonal antibodies approved for cancer treatment
Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer - Hsu - 2019 - Cancer Medicine - Wiley Online Library
MALDI-MSI of Immunotherapy: Mapping the EGFR-Targeting Antibody Cetuximab in 3D Colon-Cancer Cell Cultures | Analytical Chemistry
A: Amino Acid Sequence of Cetuximab, heavy chain chain (Source:... | Download Scientific Diagram
Automated, Kit-Based Sample Preparation Strategy for LC-MS Quantification of Cetuximab in Rat Plasma | Waters
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose | NEJM
Frontiers | Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors
SMPDB
Part:BBa K1694004 - parts.igem.org
Cetuximab–Polymersome–Mertansine Nanodrug for Potent and Targeted Therapy of EGFR-Positive Cancers | Biomacromolecules
In silico design, construction and cloning of Trastuzumab humanized monoclonal antibody: A possible biosimilar for Herceptin Akbarzadeh-Sharbaf S, Yakhchali B, Minuchehr Z, Shokrgozar MA, Zeinali S - Adv Biomed Res
Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin | Scientific Reports
Application of nano-surface and molecular-orientation limited proteolysis to LC–MS bioanalysis of cetuximab | Bioanalysis
Long noncoding RNA and mRNA profiling in cetuximab‐resistant colorectal cancer cells by RNA sequencing analysis - Jing - 2019 - Cancer Medicine - Wiley Online Library
Structure of Cetuximab | Download Scientific Diagram
RCSB PDB - 1YY8: Crystal structure of the Fab fragment from the monoclonal antibody cetuximab/Erbitux/IMC-C225
Frontiers | The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies
Antibodies | Free Full-Text | Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability
Cetuximab: Uses, Interactions, Mechanism of Action | DrugBank Online
NHRI researchers reports the effect of cetuximab-based sequential therapy as a primary treatment in advanced oral squamous cell carcinoma – NHRI Communications
Production of a germline-humanized cetuximab scFv and evaluation of its activity in recognizing EGFR- overexpressing cancer cell
Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques. - Abstract - Europe PMC
AAVrh.10-mediated expression of cetuximab. A. Design of the... | Download Scientific Diagram
Schematic representation of trastuzumab and cetuximab. Blue parts of... | Download Scientific Diagram
Amino acid sequence comparisons of the CDR regions for mAbs S25-26,... | Download Table
Cancers | Free Full-Text | Cetuximab-Mediated Protection from Hypoxia- Induced Cell Death: Implications for Therapy Sequence in Colorectal Cancer
